Automate Your Wheel Strategy on OMCL
With Tiblio's Option Bot, you can configure your own wheel strategy including OMCL - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol OMCL
- Rev/Share 25.435
- Book/Share 26.3671
- PB 1.9188
- Debt/Equity 0.1596
- CurrentRatio 1.4447
- ROIC 0.0067
- MktCap 2343234388.0
- FreeCF/Share 2.4073
- PFCF 21.0216
- PE 117.6047
- Debt/Assets 0.1
- DivYield 0
- ROE 0.016
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 5
- P/B Score 4
- D/E Score 3
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | OMCL | KeyBanc Capital Markets | Sector Weight | Overweight | -- | $60 | Jan. 8, 2026 |
| Upgrade | OMCL | Wells Fargo | Equal Weight | Overweight | -- | $35 | May 14, 2025 |
News
Omnicell (OMCL) Beats Q1 Earnings and Revenue Estimates
Published: May 06, 2025 by: Zacks Investment Research
Sentiment: Positive
Omnicell (OMCL) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.03 per share a year ago.
Read More
Omnicell Announces First Quarter 2025 Results
Published: May 06, 2025 by: Business Wire
Sentiment: Neutral
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell Announces First Quarter 2025 Results.
Read More
Why Omnicell (OMCL) is a Top Value Stock for the Long-Term
Published: April 28, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Here's Why Omnicell (OMCL) is a Strong Value Stock
Published: April 10, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Why Omnicell (OMCL) is a Top Value Stock for the Long-Term
Published: March 25, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Omnicell Gains 41.6% in a Year: What's Driving the Stock?
Published: March 05, 2025 by: Zacks Investment Research
Sentiment: Positive
OMCL's shares rise on the back of its XT Amplify program gaining market acceptance with its offerings. However, the unfavorable macroeconomic scenario is concerning.
Read More
Omnicell (OMCL) Upgraded to Buy: What Does It Mean for the Stock?
Published: February 24, 2025 by: Zacks Investment Research
Sentiment: Positive
Omnicell (OMCL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Read More
Omnicell Q4 Earnings: Ignore The Short-Term Noise
Published: February 12, 2025 by: Seeking Alpha
Sentiment: Positive
Omnicell's Q4 2024 earnings showed strong service revenue growth, despite soft overall revenue guidance, highlighting the service business as the key value driver. My updated DCF analysis yields a price target of $64.05, representing a 54% upside, and I raise my rating from buy to strong buy. The service business has grown from 6% to 22% of revenue since 2020, outpacing industry growth and improving margins, indicating long-term value.
Read More
About Omnicell, Inc. (OMCL)
- IPO Date 2001-08-09
- Website https://www.omnicell.com
- Industry Medical - Healthcare Information Services
- CEO Randall A. Lipps
- Employees 3620